Our top pick for
Vector Group Ltd is a tobacco business based in the US. Vector Group shares (VGR) are listed on the NYSE and all prices are listed in US Dollars. Vector Group employs 500 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$10.45|
|52-week range||$8.20 - $13.38|
|50-day moving average||$12.06|
|200-day moving average||$12.76|
|Wall St. target price||$14.50|
|Dividend yield||$0.8 (7.46%)|
|Earnings per share (TTM)||$1.01|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-06-23)||-2.52%|
|1 month (2022-05-27)||-16.06%|
|3 months (2022-03-26)||N/A|
|6 months (2021-12-30)||-7.52%|
|1 year (2021-06-30)||-26.10%|
|2 years (2020-06-30)||3.88%|
|3 years (2019-06-28)||7.18%|
|5 years (2017-06-29)||15.115|
Valuing Vector Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Vector Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Vector Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Vector Group shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Vector Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.96. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Vector Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Vector Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $355.7 million.
The EBITDA is a measure of a Vector Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$808.7 million|
|Operating margin TTM||41.98%|
|Gross profit TTM||$451.2 million|
|Return on assets TTM||18.32%|
|Return on equity TTM||0%|
|Market capitalisation||$1.7 billion|
TTM: trailing 12 months
Dividend payout ratio: 57.14% of net profits
Recently Vector Group has paid out, on average, around 57.14% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 7.46% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Vector Group shareholders could enjoy a 7.46% return on their shares, in the form of dividend payments. In Vector Group's case, that would currently equate to about $0.8 per share.
Vector Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Vector Group's most recent dividend payout was on 28 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 15 June 2022 (the "ex-dividend date").
Vector Group's shares were split on a 105:100 basis on 15 September 2019. So if you had owned 100 shares the day before before the split, the next day you'd have owned 105 shares. This wouldn't directly have changed the overall worth of your Vector Group shares – just the quantity. However, indirectly, the new 4.8% lower share price could have impacted the market appetite for Vector Group shares which in turn could have impacted Vector Group's share price.
Over the last 12 months, Vector Group's shares have ranged in value from as little as $8.1977 up to $13.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Vector Group's is 0.9374. This would suggest that Vector Group's shares are less volatile than average (for this exchange).
Vector Group Ltd. , through its subsidiaries, manufactures and sells cigarettes in the United States. It operates in two segments, Tobacco and Real Estate. The company produces cigarettes in 100 combinations under the EAGLE 20's, Pyramid, Montego, Grand Prix, Liggett Select, Eve, and USA brand names, as well as various partner and private label brands. It markets and sells its cigarettes to wholesalers and distributors of tobacco and convenience products, as well as grocery, drug, and convenience store chains. The company also engages in real estate investment business. The company was formerly known as Brooke Group Ltd.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.